Nationwide Surveillance in Uterine Cancer: Survival Analysis and the Importance of Birth Cohort: 30-Year Population-Based Registry in Taiwan

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Huang, Chia Yen ^a,f   Chen, Chi An ^b   Chen, Yu Li ^a   Chiang, Chun Ju ^b   Hsu, Tsui Hsia ^c   Lin, Ming Chieh ^b   Lai, Mei Shu ^b   Chen, Chien Jen ^b   You, San Lin ^d,e   Cheng, Wen Fang ^b,f  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c DEPARTMENT OF HEALTH   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSARCOMA; ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CARCINOSARCOMA; CLEAR CELL ADENOCARCINOMA; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIOID ADENOCARCINOMA; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; LEIOMYOSARCOMA; LONG TERM SURVIVAL; LOW GRADE ENDOMETRIAL STROMAL SARCOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVERALL SURVIVAL; POPULATION RESEARCH; SEROUS ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TAIWAN; TREND STUDY; UTERUS CARCINOMA; UTERUS SARCOMA;

ADULT; AGED; ANIMALS; CARCINOMA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; SURVIVAL ANALYSIS; TAIWAN; UTERINE NEOPLASMS;

EID: 84870947725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051372     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. TCRTF (2009) Taiwan Cancer Registry Task Forcec(TCRTF). Cancer Registry Annual Report. Taipei: Department of Health, The Executive Yuan; 2009.
3. Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, et al. (2008) Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol 198: 218 e211-216.
4. Boll D, Verhoeven RH, van der Aa MA, Pauwels P, Karim-Kos HE, et al. (2012) Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008. Int J Gynecol Cancer 22: 599-606.
5. Bokhman JV, (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-17.
6. Silverberg SG, Kurman RJ (1992) Tumors of the uterine corpus and gestational trophobalstic disease (3rd series). Washington, DC: Armed Forces Institute of Pathology.
7. Abeler VM, Vergote IB, Kjorstad KE, Trope CG, (1996) Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 78: 1740-1747.
8. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R, (1982) Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93-108.
9. McCluggage WG, (2002) Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12: 687-690.
10. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P, (2004) Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 95: 593-596.
11. Albrektsen G, Heuch I, Wik E, Salvesen HB, (2009) Prognostic impact of parity in 493 uterine sarcoma patients. Int J Gynecol Cancer 19: 1062-1067.
12. Olah KS, Gee H, Blunt S, Dunn JA, Kelly K, et al. (1991) Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 27: 1095-1099.
13. Olah KS, Dunn JA, Gee H, (1992) Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynaecol 99: 590-594.
14. Prat J, (2004) Prognostic parameters of endometrial carcinoma. Hum Pathol 35: 649-662.
15. Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, et al. (2010) Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 21: 1851-1856.
16. Tavassoéli FA, Devilee P (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. (IARC press, Lyon, 2003).
17. CI5 Cancer Incidence in Five Continents (CI5), Volumes 5 to 9 (http://www-dep.iarc.fr/).
18. Evans T, Sany O, Pearmain P, Ganesan R, Blann A, et al. (2011) Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer 104: 1505-1510.
19. CI5-plus Cancer Incidence in Five Continents Annual Dataset (CI5-plus), (http://ci5.iarc.fr/CI5plus/ci5plus.htm).
20. Lin CH, Chen YC, Chiang CJ, Lu YS, Kuo KT, et al. (2012) The emerging epidemic of estrogen-related cancers in young women in a developing Asian country. Int J Cancer 130: 2629-2637.
21. MacMahon B, (1974) Risk factors for endometrial cancer. Gynecol Oncol 2: 122-129.
22. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S, (1991) The epidemiology of endometrial cancer. Gynecol Oncol 41: 1-16.
23. Lee MM, Chang IY, Horng CF, Chang JS, Cheng SH, et al. (2005) Breast cancer and dietary factors in Taiwanese women. Cancer Causes Control 16: 929-937.
24. Yang PS, Yang TL, Liu CL, Wu CW, Shen CY, (1997) A case-control study of breast cancer in Taiwan-a low-incidence area. Br J Cancer 75: 752-756.
25. Lai FM, Chen P, Ku HC, Lee MS, Chang SC, et al. (1996) A case-control study of parity, age at first full-term pregnancy, breast feeding and breast cancer in Taiwanese women. Proc Natl Sci Counc Repub China B 20: 71-77.
26. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, et al. (1992) Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167: 1317-1325.
27. Lin YC, Yen LL, Chen SY, Kao MD, Tzeng MS, et al. (2003) Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996. Prev Med 37: 233-241.
28. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG, (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19: 3119-3130.
29. Chen ML, Chen JS, Tang CL, Mao IF, (2008) The internal exposure of Taiwanese to phthalate-an evidence of intensive use of plastic materials. Environ Int 34: 79-85.
30. Chen CY, Wen TY, Wang GS, Cheng HW, Lin YH, et al. (2007) Determining estrogenic steroids in Taipei waters and removal in drinking water treatment using high-flow solid-phase extraction and liquid chromatography/tandem mass spectrometry. Sci Total Environ 378: 352-365.
31. Fang GC, Wu YS, Fu PP, Yang IL, Chen MH, (2004) Polycyclic aromatic hydrocarbons in the ambient air of suburban and industrial regions of central Taiwan. Chemosphere 54: 443-452.
32. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, et al. (2006) Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 94: 642-646.
33. Piver MS, Rutledge FN, Copeland L, Webster K, Blumenson L, et al. (1984) Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 64: 173-178.
34. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60: 2035-2041.
35. Abeler VM, Kjorstad KE, Berle E, (1992) Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population. Int J Gynecol Cancer 2: 9-22.
36. Nordal RR, Thoresen SO, (1997) Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer 33: 907-911.
37. Kay S, (1957) Clear-cell carcinoma of the endometrium. Cancer 10: 124-130.
38. Silverberg SG, De Giorgi LS, (1973) Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings. Cancer 31: 1127-1140.
39. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, et al. (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29-33.
40. Mariani A, Webb MJ, Galli L, Podratz KC, (2000) Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76: 348-356.
41. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, et al. (2011) Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol 29: 832-838.
42. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP, (2000) The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89: 1765-1772.
43. Park JY, Park SK, Kim DY, Kim JH, Kim YM, et al. (2011) The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol 122: 255-259.